GUIDE
Free Systematic Review Software: What's Actually Free in 2026
Last reviewed September 14, 2026
"Free systematic review software" means five different things depending which provider you ask. Some free tiers are permanent but capped by review count; some are permanent only if your project stays public; some are only a trial before a paid annual license kicks in; and one is free only for a specific kind of review at a specific organization. We checked each provider's own current pricing page directly (linked in the table) rather than relying on marketing copy, so you can see exactly what "free" buys before you commit a real review to a tool.
What each free tier actually includes
| Tool | Free tier includes | The catch | Source |
|---|---|---|---|
| EvidenceFlow | Import, dedup, screening, extraction, meta-analysis, PRISMA - no review-count cap, no seat limit, private reviews included | AI-assisted screening, extraction auto-fill, and manuscript drafting are a ₹399/month upgrade | evidenceflow.in/pricing |
| Rayyan | 3 active reviews, 2 collaborators, PRISMA diagrams, blind dual screening | Reviews beyond 3 (or teams beyond 2) require a paid seat, from $4.99/seat/month | rayyan.ai/pricing |
| Covidence | Free trial only - up to 500 records | No ongoing free plan - a real review needs a paid annual license from $339/year | covidence.org/pricing/ |
| RevMan | Free for Cochrane authors producing an actual Cochrane review | Not free otherwise - non-Cochrane use needs a paid annual subscription (discounted for students/academics) | cochrane.org/revman-individuals |
| Sysrev | Unlimited public projects and reviewers, forever | Only public - a private review needs the $50/member/month Premium plan | sysrev.com/pricing |
Sources checked September 14, 2026: evidenceflow.in/pricing, rayyan.ai/pricing, covidence.org/pricing/, cochrane.org/revman-individuals, sysrev.com/pricing.
The two kinds of "free"
Three of these five - EvidenceFlow, Rayyan, and Sysrev - have a genuinely permanent free tier: you can keep using it indefinitely without a credit card, subject to a specific condition (a review-count cap, a collaborator cap, or a public-only requirement). Covidence and RevMan are structurally different: Covidence's free tier is a time-and-record-limited trial that funnels into a paid annual license, and RevMan is free only for the specific case of an author producing an official Cochrane review - everyone else pays.
The condition attached to each permanent free tier matters more than the word "free" itself. Rayyan's cap is on review count (3 active reviews); Sysrev's cap is on visibility (the project must stay public, which rules out most real research involving unpublished or sensitive data); EvidenceFlow's core workflow has neither cap, with the paid tier reserved for AI-assistance features rather than for unlocking the workflow itself.
Which free tier fits your situation
- Running one private review, want screening through meta-analysis: EvidenceFlow's free tier covers the whole workflow with no review-count cap.
- Running a small number of reviews and mainly need screening: Rayyan's free tier (3 active reviews) is a well-established option, with exports elsewhere for analysis.
- Working on an open, public evidence map or dataset: Sysrev's free tier is built for exactly this, with no limit on public projects or reviewers.
- Producing an official Cochrane review: RevMan is the required tool and free for that specific purpose - no free alternative applies here.
- Evaluating Covidence: budget for the paid license once you're past the 500-record trial - there's no ongoing free plan to fall back on.
Feature availability, limits, and pricing vary by plan and can change - this is a starting point for your own evaluation, not a substitute for it. See our full comparisons with Rayyan, Covidence, RevMan, and Sysrev.
FAQ
Which systematic review tool is actually free, not just free-to-try?
EvidenceFlow, Rayyan, and Sysrev all have an ongoing free tier you can use indefinitely, not just a trial. Rayyan's is capped at 3 active reviews; Sysrev's requires the project to stay public; EvidenceFlow's core workflow (including private reviews) has no review-count cap. Covidence has no ongoing free plan, only a 500-record trial. RevMan is free only if you're producing an actual Cochrane review.
Can I run a real, private systematic review without paying anything?
With EvidenceFlow, yes - the core import-through-meta-analysis workflow is free with private reviews included. With Rayyan, yes, as long as you stay within 3 active reviews. With Sysrev, no - private projects require the paid Premium plan. With Covidence, no - there's no ongoing free plan.
Is a free plan actually good enough, or do I need to pay eventually?
That depends on what you need. If you need AI-assisted screening suggestions, extraction auto-fill, or you're running more reviews than a free tier allows, you'll hit a paid tier somewhere. This page describes what's included at $0 today - check each provider's current pricing page before committing a review to one, since limits and prices change.
Core import, screening, extraction, meta-analysis, and PRISMA reporting are free with no subscription or seat limits, and private reviews are included.